We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$210M
AUM Growth
+$7.69M
Cap. Flow
+$4.27M
Cap. Flow %
2.03%
Top 10 Hldgs %
44.48%
Holding
178
New
16
Increased
72
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$840K
2
AAPL icon
Apple
AAPL
+$728K
3
MO icon
Altria Group
MO
+$501K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$439K
5
SNAP icon
Snap
SNAP
+$408K

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Communication Services 11.14%
3 Healthcare 9.45%
4 Consumer Discretionary 7.27%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.88T
$18.8M 8.93%
490,020
+18,768
+4% +$728K
IJH icon
2
iShares Core S&P Mid-Cap ETF
IJH
$123B
$12.3M 5.83%
342,680
-560
-0.2% -$19.5K
IVW icon
3
iShares S&P 500 Growth ETF
IVW
$72.9B
$11.8M 5.61%
330,340
-4,068
-1% -$143K
AMZN icon
4
Amazon
AMZN
$2.51T
$11.2M 5.32%
234,060
-7,380
-3% -$363K
IVE icon
5
iShares S&P 500 Value ETF
IVE
$48.9B
$9.01M 4.28%
83,658
-768
-0.9% -$81.3K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$8.35M 3.97%
172,980
-3,180
-2% -$151K
NFLX icon
7
Netflix
NFLX
$292B
$6.73M 3.2%
372,530
-3,000
-0.8% -$52.3K
GOOG icon
8
Alphabet (Google) Class C
GOOG
$3.91T
$6M 2.85%
126,200
+780
+0.6% +$36.3K
IJR icon
9
iShares Core S&P Small-Cap ETF
IJR
$109B
$5.67M 2.7%
76,651
-3,408
-4% -$239K
MO icon
10
Altria Group
MO
$121B
$3.74M 1.78%
58,264
+7,512
+15% +$501K
LQD icon
11
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$3.42M 1.63%
28,224
+357
+1% +$43.1K
SLYV icon
12
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.9B
$3.36M 1.6%
53,338
+196
+0.4% +$11.6K
NVO
13
Novo Nordisk
NVO
$217B
$2.98M 1.42%
123,820
+1,964
+2% +$44.4K
PFF icon
14
iShares Preferred and Income Securities ETF
PFF
$13.2B
$2.94M 1.4%
75,843
+1,056
+1% +$41.1K
FTEC icon
15
Fidelity MSCI Information Technology Index ETF
FTEC
$20B
$2.76M 1.31%
60,194
-1,436
-2% -$64.5K
MMM icon
16
3M
MMM
$88.2B
$2.72M 1.29%
15,538
+488
+3% +$84.6K
ISRG icon
17
Intuitive Surgical
ISRG
$121B
$2.61M 1.24%
22,842
+7,713
+51% +$840K
HYG icon
18
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$2.6M 1.24%
29,303
+1,781
+6% +$157K
FHLC icon
19
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$2.5M 1.19%
63,662
-1,640
-3% -$63.5K
GUSH icon
20
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$249M
$2.41M 1.14%
975
+129
+15% +$249K
GILD icon
21
Gilead Sciences
GILD
$161B
$2.29M 1.09%
28,290
+3,210
+13% +$245K
STZ icon
22
Constellation Brands
STZ
$22.3B
$2.27M 1.08%
11,410
+437
+4% +$86.5K
SPXL icon
23
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.63B
$2.16M 1.03%
56,949
+1,290
+2% +$46.4K
CELG
24
DELISTED
Celgene Corp
CELG
$2.08M 0.99%
14,548
+344
+2% +$46.9K
AGG icon
25
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.94M 0.92%
17,656
+545
+3% +$59.8K

Similar funds

Traynor Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Traynor Capital Management held 178 positions worth $210M, up 3.8% from $203M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Traynor Capital Management's Q3 2017 filing shows 16 new, 72 increased, 69 reduced and 10 closed positions. Its largest new stake was Teva Pharmaceuticals: 19,502 shares worth $335K. The largest sale was Alnylam Pharmaceuticals, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Healthcare.

  • Traynor Capital Management's largest Q3 2017 buy was Teva Pharmaceuticals: 19,502 shares worth $335K.
  • Traynor Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $840K increase.
  • Traynor Capital Management's biggest Q3 2017 reduction was Amazon, cutting an estimated $363K.
  • Traynor Capital Management fully exited Alnylam Pharmaceuticals in Q3 2017, selling an estimated $516K.
  • Traynor Capital Management's ten largest holdings make up 44% of its $210M portfolio in Q3 2017.
  • Traynor Capital Management opened 16 new positions and closed 10 in Q3 2017.
  • Traynor Capital Management's portfolio value rose 3.8% quarter-over-quarter to $210M.

Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.